The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy

• Chunling Huang ,

  Contributed equally to this work with: Chunling Huang, Ling Zhang

  Roles Data curation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Kolling Institute, Sydney Medical School-Northern, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia

  http://orcid.org/0000-0002-5410-4935

  ⨯
• Ling Zhang ,

  Contributed equally to this work with: Chunling Huang, Ling Zhang

  Roles Data curation, Methodology

  Affiliation School of Pharmaceutical Science &Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kuming, China

  ⨯
• Ying Shi,

  Roles Methodology

  Affiliation Kolling Institute, Sydney Medical School-Northern, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia

  ⨯
• Hao Yi,

  Roles Methodology

  Affiliation Kolling Institute, Sydney Medical School-Northern, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia

  ⨯
• Yongli Zhao,

  Roles Methodology

  Affiliation Department of Pediatrics, the Second Hospital of Dalian Medical University, Dalian, Liaoning, China

  ⨯
• Jason Chen,

  Roles Methodology

  Affiliation Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales, Australia

  ⨯
• Carol A. Pollock ,

  Roles Supervision, Writing – review & editing

  * E-mail: carol.pollock@sydney.edu.au

  Affiliation Kolling Institute, Sydney Medical School-Northern, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia

  ⨯
• Xin-Ming Chen

  Roles Supervision, Writing – review & editing

  Affiliation Kolling Institute, Sydney Medical School-Northern, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia

  ⨯